attenuated live listeria encoding hpv 16 e7 vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2011 (NCT01266460)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human papillomavirusImmunity, active
Human papillomavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- attenuated live listeria encoding hpv 16 e7 vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01266460 | Phase 2 | May 1, 2011 | Advaxis, Inc., Gynecologic Oncology Group, National Cancer Institute (NCI), NRG Oncology |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Advaxis, Inc. | For profit | 1 | 0 | 1 | 2011 |
| Gynecologic Oncology Group | Academic/Hospital | 1 | 1 | 1 | 2011 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2011 |
| NRG Oncology | Academic/Hospital | 1 | 0 | 1 | 2011 |
4 organizations
Page 1 / 1